Although previous studies did not present the FNRs of these procedures according to the subtypes, we expect that these surgical procedures may improve the accuracy of axillary staging in non-complete MRI responders with HER2+ or TNBC or in those with HR+ HER2− breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.